Neghizyl (Ibuprofen Lysine)

Ibuprofen lysine, the active ingredient in Neghizyl, is a nonsteroidal anti‑inflammatory drug presented as an oral dosage form for oral use. It treats mild to moderate pain, fever, and inflammatory conditions in adults and children as directed by a healthcare professional.

GNH USA supplies Neghizyl as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ibuprofen lysine is an NSAID that alleviates pain, reduces fever, and controls inflammation across several clinical settings.

- Mild to moderate pain: provides rapid analgesic relief for headaches, dental pain, musculoskeletal discomfort, and postoperative pain. - Fever: lowers elevated body temperature associated with infections or inflammatory processes. - Inflammatory conditions (e.g., arthritis, sprains): diminishes swelling and improves joint mobility.

Adverse reactions may range from mild to severe and should be monitored during therapy.

Common Side Effects: - Gastrointestinal upset: nausea, dyspepsia, or abdominal discomfort. - Headache or dizziness. - Mild skin rash or itching. - Transient increase in blood pressure.

Serious or Rare Side Effects: - Gastrointestinal bleeding, ulceration, or perforation. - Acute renal impairment or worsening of chronic kidney disease. - Severe hypersensitivity reactions, including anaphylaxis. - Hepatotoxicity presenting as elevated liver enzymes. - Stevens‑Johnson syndrome or toxic epidermal necrolysis.

Before initiating therapy, consider the following safety measures.

- Assess renal function: adjust use in patients with impaired kidney function. - Monitor gastrointestinal risk: co‑prescribe with food or protective agents in high‑risk individuals. - Avoid in known hypersensitivity to ibuprofen, other NSAIDs, or aspirin. - Use cautiously with anticoagulants or antiplatelet agents due to increased bleeding risk. - Store at ambient temperature below 25°C: keep in the original pack, protect from moisture.

Ibuprofen lysine can interact with several drug classes; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Concurrent anticoagulants (e.g., warfarin): heightened risk of serious bleeding. - Combination with other NSAIDs or COX‑2 inhibitors: additive gastrointestinal toxicity. - Use with selective serotonin reuptake inhibitors (SSRIs): increased hemorrhagic potential.

Moderate Interactions (Monitor Closely): - ACE inhibitors or diuretics: possible decline in renal function. - Lithium therapy: ibuprofen may raise serum lithium concentrations. - Methotrexate: reduced clearance may lead to toxicity.